Xinglong Xing

Title: Xinglong Xing and His Patent on Kinase Inhibitors.

Introduction

Xinglong Xing is an inventor associated with Suzhou, China. His reported patent work concerns compounds designed to inhibit protein kinases, which are involved in various biological processes.

Latest Patents

Xing’s listed patent is “5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors.” The invention describes compounds of Formula I or II and their potential use in treating conditions mediated by protein kinases, including VEGFR2, c-Met, PDGFRβ, c-Kit, CSF1R, and EphA2. The available information lists 1 patent for Xing.

Career Highlights

Xing is associated with Ascepion Pharmaceuticals, Inc. His listed patent reflects work in medicinal chemistry and the development of compounds targeting protein kinases.

Collaborations

Qishan Wang and Shan Jiang are identified as Xing’s coworkers. Their names are also associated with the collaborative context of his patent work.

Conclusion

Xinglong Xing’s listed invention focuses on 5,6-bicyclic heteroaryl-containing urea compounds and their potential application as kinase inhibitors.